LU77764A1 - - Google Patents

Info

Publication number
LU77764A1
LU77764A1 LU77764A LU77764A LU77764A1 LU 77764 A1 LU77764 A1 LU 77764A1 LU 77764 A LU77764 A LU 77764A LU 77764 A LU77764 A LU 77764A LU 77764 A1 LU77764 A1 LU 77764A1
Authority
LU
Luxembourg
Application number
LU77764A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU77764A1 publication Critical patent/LU77764A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
LU77764A 1976-07-16 1977-07-14 LU77764A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
LU77764A1 true LU77764A1 (xx) 1978-02-02

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77764A LU77764A1 (xx) 1976-07-16 1977-07-14

Country Status (29)

Country Link
US (1) US4080454A (xx)
JP (1) JPS5337673A (xx)
AR (1) AR213652A1 (xx)
AT (1) AT351561B (xx)
BE (1) BE856710A (xx)
CA (1) CA1061788A (xx)
CH (1) CH622512A5 (xx)
CS (1) CS212264B2 (xx)
DD (1) DD131556A5 (xx)
DE (1) DE2731736A1 (xx)
DK (1) DK139029B (xx)
EG (1) EG12762A (xx)
ES (1) ES460686A1 (xx)
FI (1) FI772183A (xx)
FR (1) FR2358399A1 (xx)
GB (1) GB1542178A (xx)
GR (1) GR68686B (xx)
HU (1) HU177713B (xx)
IL (1) IL52409A (xx)
LU (1) LU77764A1 (xx)
NL (1) NL7707729A (xx)
NO (1) NO772489L (xx)
PH (1) PH13190A (xx)
PL (1) PL103783B1 (xx)
PT (1) PT66808B (xx)
SE (1) SE421125B (xx)
SU (1) SU673169A3 (xx)
YU (1) YU171677A (xx)
ZA (1) ZA773927B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
AU2006283211B2 (en) 2005-08-22 2012-06-21 Melior Pharmaceuticals I, Inc. Methods and formulations for modulating Lyn kinase activity and treating related disorders
CA2678813A1 (en) * 2007-02-20 2008-08-28 Melior Pharmaceuticals I, Inc. Methods of identifying activators of lyn kinase
MX2009009693A (es) * 2007-07-23 2009-10-07 Melior Discovery Inc Metodos para activar irs-1 y akt.
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
MX2019012170A (es) 2017-04-10 2020-01-20 Melior Pharmaceuticals I Inc Tratamiento de adipocitos.
US20210106581A1 (en) 2018-02-21 2021-04-15 Melior Pharmaceuticals I, Inc. Treatment Of Liver Diseases

Also Published As

Publication number Publication date
DK318177A (xx) 1978-01-17
YU171677A (en) 1982-06-30
ZA773927B (en) 1978-05-30
JPS5512017B2 (xx) 1980-03-29
CS212264B2 (en) 1982-03-26
IL52409A (en) 1979-11-30
US4080454A (en) 1978-03-21
GR68686B (xx) 1982-02-01
SE7707471L (sv) 1978-01-17
AU2663877A (en) 1978-05-18
PH13190A (en) 1980-01-16
DD131556A5 (de) 1978-07-05
EG12762A (en) 1979-12-31
PT66808A (en) 1977-08-01
SU673169A3 (ru) 1979-07-05
FR2358399B1 (xx) 1980-10-17
GB1542178A (en) 1979-03-14
SE421125B (sv) 1981-11-30
IL52409A0 (en) 1977-08-31
DK139029B (da) 1978-12-04
PL103783B1 (pl) 1979-07-31
NL7707729A (nl) 1978-01-18
FR2358399A1 (fr) 1978-02-10
BE856710A (fr) 1978-01-11
DE2731736A1 (de) 1978-01-26
JPS5337673A (en) 1978-04-06
HU177713B (en) 1981-12-28
CA1061788A (en) 1979-09-04
ATA509277A (de) 1979-01-15
DK139029C (xx) 1979-05-07
PL199633A1 (pl) 1978-04-10
FI772183A (xx) 1978-01-17
PT66808B (en) 1978-12-21
CH622512A5 (xx) 1981-04-15
AR213652A1 (es) 1979-02-28
NO772489L (no) 1978-01-17
ES460686A1 (es) 1978-12-01
AT351561B (de) 1979-08-10

Similar Documents

Publication Publication Date Title
FR2358399B1 (xx)
JPS5721860Y2 (xx)
JPS5515534Y2 (xx)
JPS5652238B2 (xx)
JPS562206Y2 (xx)
JPS52156028U (xx)
JPS5372365U (xx)
JPS52140147U (xx)
JPS52103493U (xx)
CH608607A5 (xx)
CH597659A5 (xx)
CH595874A5 (xx)
CH598217A5 (xx)
CH614527A5 (xx)
CH612980A5 (xx)
CH612600A5 (xx)
CH612326A5 (xx)
CH604281A5 (xx)
CH611705A5 (xx)
CH611493A5 (xx)
CH609390A5 (xx)
CH595430A5 (xx)
CH609293A5 (xx)
CH609140A5 (xx)
CH608715A5 (xx)